ArticleCureus2026
Predictors of Critical Care Interventions and Length of Stay in Pediatric Sickle Cell Acute Chest Syndrome: A Five-Year Pediatric Intensive Care Unit (PICU) Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Acute chest syndrome (ACS) remains one of the most severe complications of pediatric sickle cell anemia (SCA) and a leading cause of Pediatric Intensive Care Unit (PICU) admission. Despite its clinical significance, regional data describing PICU-level characteristics, interventions, and outcomes in children with SCA are limited. This study aimed to evaluate the clinical profile, management strategies, and outcomes of pediatric SCA patients admitted to the PICU at a tertiary care center in Tabuk, Saudi Arabia. Methods We conducted a retrospective cohort study of pediatric patients aged one to 14 years with confirmed SCA admitted to the PICU for ACS between January 2020 and January 2025 (five-year period) at King Salman Armed Forces Hospital, Tabuk. Demographic data, laboratory parameters, prior disease history, PICU interventions, and clinical outcomes were extracted from medical records. Associations between clinical predictors and major interventions were evaluated using chi-square/Fisher's exact testing. Predictors of PICU length of stay were analyzed using comparative statistical methods. Results Forty-one patients were included (mean age 8.71 ± 3.54 years); 25 (61.0%) were male. Most patients had the homozygous sickle cell disease (HbSS) genotype (36 (87.8%)), and 30 (73.2%) were receiving hydroxyurea. Exchange transfusion was performed in 29 (70.7%) admissions, while mechanical ventilation was required in two (4.9%). Exchange transfusion was not significantly associated with demographic or baseline clinical variables. Although Fisher's exact testing demonstrated statistical significance for prior ICU admission (p = 0.034) and prior stroke (p = 0.007), the very small number of ventilation events (n = 2) limits the robustness of these associations. These findings should therefore be interpreted with caution. Mean PICU length of stay was 3.24 ± 2.80 days and was significantly longer among patients with a history of stroke (p = 0.003). In-PICU complications were uncommon. Conclusion In this five-year single-center retrospective cohort of pediatric patients with SCA admitted to the PICU for ACS, exchange transfusion was frequently utilized, whereas invasive mechanical ventilation was uncommon. A signal toward greater PICU severity was observed among patients with prior neurologic events or prior ICU exposure; however, given the small sample size and limited number of ventilation events, these observations should be interpreted with caution. Larger, multicenter prospective studies are needed to further clarify risk stratification and inform evidence-based critical care planning in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.